Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...

Multipotency of Hematopoietic Stem Cells

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Use of the sublingual gland for reconstruction of a defect in the floor of the mouth after resection of early stage carcinoma.

The British journal of oral & maxillofacial surgery·2020

Same author

[Pharmacotherapeutics for the new coronavirus pneumonia].

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases·2020

Same author

[The keypoints in treatment of the critical coronavirus disease 2019 patient(1)].

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases·2020

Same author

[Pharmacotherapeutics for the New Coronavirus Pneumonia].

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases·2020

Same author

RBMS3 delays disc degeneration by inhibiting Wnt/β-catenin signaling pathway.

European review for medical and pharmacological sciences·2020

Same author

Long noncoding RNA SNHG14 acts as an oncogene in prostate cancer via targeting miR-613.

European review for medical and pharmacological sciences·2020

Search research articles

Related Experiment Video

Updated: Jun 20, 2026

Comparison of Two Representative Methods for Differentiation of Human Induced Pluripotent Stem Cells into Mesenchymal Stromal Cells

Comparison of Two Representative Methods for Differentiation of Human Induced Pluripotent Stem Cells into Mesenchymal Stromal Cells

Published on: October 20, 2023

Histone deacetylase inhibitors decrease proliferation potential and multilineage differentiation capability of human

S Lee¹, J-R Park, M-S Seo

¹Adult Stem Cell Research Center, Seoul National University, Seoul, South Korea.

Cell Proliferation

|August 20, 2009

Summary

This summary is machine-generated.

Histone deacetylase (HDAC) inhibitors, valproic acid and sodium butyrate, impair mesenchymal stem cell (MSC) self-renewal and multipotency. HDAC activity is crucial for maintaining MSC self-renewal and differentiation potential.

More Related Videos

Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells (MSCs)

Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells (MSCs)

Published on: December 24, 2015

Assays for Validating Histone Acetyltransferase Inhibitors

Assays for Validating Histone Acetyltransferase Inhibitors

Published on: August 6, 2020

Related Experiment Videos

Last Updated: Jun 20, 2026

Comparison of Two Representative Methods for Differentiation of Human Induced Pluripotent Stem Cells into Mesenchymal Stromal Cells

Comparison of Two Representative Methods for Differentiation of Human Induced Pluripotent Stem Cells into Mesenchymal Stromal Cells

Published on: October 20, 2023

Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells (MSCs)

Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells (MSCs)

Published on: December 24, 2015

Assays for Validating Histone Acetyltransferase Inhibitors

Assays for Validating Histone Acetyltransferase Inhibitors

Published on: August 6, 2020

Area of Science:

Stem Cell Biology
Epigenetics
Cancer Therapeutics

Background:

Histone deacetylase (HDAC) inhibitors are investigated for cancer therapy due to their roles in differentiation and proliferation.
Mesenchymal stem cells (MSCs) possess self-renewal and multipotency, making them relevant for regenerative medicine and cancer research.

Purpose of the Study:

To investigate the role of HDACs in maintaining the self-renewal and proliferation of MSCs.
To determine the effect of HDAC inhibition on MSC multipotency and differentiation capacity.

Main Methods:

Human MSCs from adipose tissue and umbilical cord blood were treated with HDAC inhibitors (valproic acid and sodium butyrate).
Cell proliferation was assessed using MTT assays; cell cycle progression was analyzed by flow cytometry.
In vitro differentiation assays (osteogenic, adipogenic, neurogenic, chondrogenic) and molecular analyses (immunocytochemistry, Western blot, RT-PCR) were performed.

Main Results:

HDAC inhibition by VPA and NaBu reduced MSC proliferation and blocked the cell cycle at the G2/M phase.
HDAC inhibitors decreased the efficiency of adipogenic, chondrogenic, and neurogenic differentiation.
Conversely, osteogenic differentiation was enhanced by HDAC inhibitor treatment.

Conclusions:

HDAC activity is essential for maintaining MSC self-renewal and pluripotency.
HDAC inhibition affects MSC differentiation potential, highlighting a critical role in stem cell maintenance.